Taiwanese tech firm i2i to invest up to $70 million in Israeli startups through new program
Thus far, 25 Israeli startups have been selected for the program, eight of which have already signed cooperation agreements to pilot their technologies and products
Taiwan’s largest innovation company, Innovation to Industry (i2i), has launched a program named IP² LaunchPad, which provides Israeli startups with exposure to the growing East Asian markets, i2i announced Sunday. The program also grants the Israeli startups access to investments from $200,000 in the first phase and up to $3 million at the end of the program.
The purpose of the program is to create collaborations between Israeli startups and the technology and healthcare markets in Taiwan, to connect Israeli companies with leading strategic partners from the manufacturing and distribution industry, Taiwan’s health care system, and potential investors.
IP² is managed in Israel by the Israeli consulting firm Healthier Globe headed by Rani Shifron.
Thus far, 25 Israeli startups have been selected for the program, eight of which have already signed cooperation agreements to pilot their technologies and products, conduct feasibility studies, or clinically validate their technologies. The startups reign from the fields of digital health, cybersecurity, and artificial intelligence internet of things (AIOT).
The eight startups are Ezmems Ltd. that develops smart plastic sensors for ventilators; Cybord that develops technologies that stop counterfeit, defective and malicious electronic components from getting assembled into products during the manufacturing process; Tenuto that develops a liquid biopsy test to analyze different tumors; ReSymmetry Corp. that develops smart robotic wheelchair systems that integrate movement into the sitting posture; Serenno Medical that develops a novel method to monitor urine output, fluid balance, and predict, identify, and avoid Acute Kidney Injury; Cardio-Core that manufactures a medical-grade ECG, PPG, Blood pressure OEM module; Libra@Home is a neurorehabilitation company developing virtual-reality tools to improve the quality and delivery of treatment for patients with neurological impairments; and PathKeeper Surgical that develops technologies for surgeries, including a 3D camera installed in the operation room that tracks the patients and the surgeon’s tools during the entire surgery.